Skip to content
Open access · US-GOV via ClinicalTrials.gov Clinical trial

Identification of Aging Biomarkers for Better Tailoring of Cancer Treatment in Older Patients With Lung Cancer: a Multicenter Clinico-biological Cohort Study

Authors not listed

Assistance Publique - Hôpitaux de Paris · 2025

Abstract

The main objective is to identify and assess the predictive value of ageing and senescence(definition) biomarkers (methylome, telomeres, inflammageing) and senescent cells in tissues to improve prognosis assessment older patients with locally or locally-advanced Non-Small Cell Lung Cancer (NSCLC).

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
ClinicalTrials.gov
Canonical
link ↗
Fetched
2026-10-22 MST

Cite this

APA
Anonymous. (2025). Identification of Aging Biomarkers for Better Tailoring of Cancer Treatment in Older Patients With Lung Cancer: a Multicenter Clinico-biological Cohort Study. <em>Assistance Publique - Hôpitaux de Paris</em>. https://clinicaltrials.gov/study/NCT06923618
Vancouver
Anonymous. Identification of Aging Biomarkers for Better Tailoring of Cancer Treatment in Older Patients With Lung Cancer: a Multicenter Clinico-biological Cohort Study. Assistance Publique - Hôpitaux de Paris. 2025.
BibTeX
@misc{anon2025Identi, title = {Identification of Aging Biomarkers for Better Tailoring of Cancer Treatment in Older Patients With Lung Cancer: a Multicenter Clinico-biological Cohort Study}, author = {Anonymous}, journal = {Assistance Publique - Hôpitaux de Paris}, year = {2025}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings